Daiwa Securities Group
FOMX

Daiwa Securities Group’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History

Daiwa Securities Group’s Portfolio FOMX Stock Details FOMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-389
Closed -$1K – 1246
2019
Q4 		$1K Hold
389
– – ﹤0.01% 1196
2019
Q3 		$1K Buy
389
+182
+88% +$512 ﹤0.01% 1175
2019
Q2 		$0 Hold
207
– – ﹤0.01% 1237
2019
Q1 		$1K Buy
+207
New +$776 ﹤0.01% 1178
2018
Q4 		– Sell
-207
Closed -$1K – 1214
2018
Q3 		$1K Hold
207
– – ﹤0.01% 1160
2018
Q2 		$1K Hold
207
– – ﹤0.01% 1181
2018
Q1 		$1K Buy
+207
New +$1.25K ﹤0.01% 1167

Daiwa Securities Group's FOMX Position: Q1 2020 in Review

Daiwa Securities Group sold out of Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) in Q1 2020, closing a stake of 389 shares — an estimated $1K sold.

Daiwa Securities Group first reported a position in FOMX in Q1 2018 and held it in 7 quarters. The position peaked at $1K in Q4 2019. 3 funds tracked by Wall St. Rank hold FOMX as of Q1 2020.

  • Daiwa Securities Group reported no remaining Foamix Pharmaceuticals Ltd. Ordinary Shares position as of Q1 2020 after selling out during the quarter.
  • Daiwa Securities Group sold 389 Foamix Pharmaceuticals Ltd. Ordinary Shares shares in Q1 2020, an estimated $1K.
  • Daiwa Securities Group first reported a position in Foamix Pharmaceuticals Ltd. Ordinary Shares in Q1 2018 and held it in 7 quarters.
  • Daiwa Securities Group's Foamix Pharmaceuticals Ltd. Ordinary Shares position peaked at $1K in Q4 2019.
  • 3 funds tracked by Wall St. Rank held Foamix Pharmaceuticals Ltd. Ordinary Shares as of Q1 2020.

Based on Daiwa Securities Group's 13F filing for Q1 2020, filed 14 May 2020.